The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife
Soluble CD40 Ligand (human, recombinant; His-tagged) (TNF-related Activation Protein, CD40L, TNF Superfamily Member 5, T-B Cell-activating Molecule, T Cell Antigen Gp39, CD154) | Cayman Chemical
The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife
Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells - ScienceDirect
CD40 low is a marker for coimmunization-induced DCregs. (A) Mice were... | Download Scientific Diagram
Frontiers | The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis | Journal of the American College of Cardiology
The CD40/CD40 Ligand System: Linking Inflammation With Atherothrombosis | Journal of the American College of Cardiology
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
36-3609-Anti-CD40 Ligand Monoclonal Antibody(Clone: CD40LG/2761)
Multiple effects of CD40-CD40L axis in immunity against infection and | ITT
CD154 - Wikipedia
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders - The Lancet Rheumatology
Staining of CD40 as an Activation Marker on Murine Splenocytes | Biocompare Antibody Review
CD40-CD40L and Platelet Function | Circulation Research
CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1)
The role of CD40 and CD154/CD40L in dendritic cells - ScienceDirect
CD40 (protein) - Wikipedia
Frontiers | CD40L and Its Receptors in Atherothrombosis—An Update
CD40L and its receptors: the binding of CD40L to CD40, αIIbβ3, α5β1, or... | Download Scientific Diagram
Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
Immune Check Point CD40–CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells | Anticancer Research
